乳腺癌保乳术后乳房水肿危险因素分析及风险预测模型研究
Analysis of Risk Factors and Risk Prediction Model of Breast Edema after Breast-Conserving Surgery for Breast Cancer
DOI: 10.12677/jcpm.2026.52171, PDF,   
作者: 张 赫:内蒙古科技大学包头医学院临床医学系,内蒙古 包头;朱敬军*:包头市肿瘤医院乳腺中心B区,内蒙古 包头
关键词: 乳房水肿淋巴水肿保乳手术乳腺癌危险因素列线图Breast Edema Lymphedema Breast Conserving Surgery Breast Cancer Risk Factors Nomogram
摘要: 目的:明确乳腺癌保乳术后乳房水肿发生率及独立危险因素,构建并初步验证风险预测列线图,为临床早期识别高危人群、实施个体化干预提供参考。方法:连续纳入2023年11月至2025年11月包头市肿瘤医院200例保乳手术女性乳腺癌患者,明确乳房水肿诊断标准,收集相关临床及心理数据;经单因素分析、LASSO回归变量降维及多因素Logistic回归筛选独立危险因素,构建列线图,通过Bootstrap重采样及多种方法评估模型性能。结果:200例患者中50例发生乳房水肿,发生率25.0%,中位发生时间8个月;BMI、乳房CTV体积等7项为独立危险因素(均P < 0.05),构建的列线图AUC为0.866,校准度、稳定性良好,2%~8%阈值范围内有临床净获益。结论:乳腺癌保乳术后乳房水肿发生率较高,上述7项为独立危险因素,其列线图可作为临床个体化风险评估及早期干预的参考。
Abstract: Objective: To determine the incidence of breast edema and its independent risk factors after breast-conserving surgery for breast cancer, construct and preliminarily validate a risk prediction column chart, and provide a reference for early clinical identification of high-risk populations and implementation of individualized interventions. Methods: A total of 200 female breast cancer patients who underwent breast-conserving surgery at Baotou Cancer Hospital from November 2023 to November 2025 were consecutively enrolled. Diagnostic criteria for breast edema were established, and relevant clinical and psychological data were collected. Independent risk factors were screened through univariate analysis, LASSO regression variable dimensionality reduction, and multivariate logistic regression. A column chart was constructed, and model performance was evaluated using Bootstrap resampling and multiple methods. Results: Among the 200 patients, 50 developed breast edema, with an incidence rate of 25.0% and a median occurrence time of 8 months. Seven factors, including BMI and breast CTV volume, were identified as independent risk factors (all P < 0.05). The AUC of the constructed column chart was 0.866, demonstrating good calibration and stability, with clinical net benefit within the 2%~8% threshold range. Conclusion: The incidence of breast edema after breast-conserving surgery for breast cancer is relatively high, and the aforementioned seven factors are independent risk factors. The column chart can serve as a reference for clinical individualized risk assessment and early intervention.
文章引用:张赫, 朱敬军. 乳腺癌保乳术后乳房水肿危险因素分析及风险预测模型研究[J]. 临床个性化医学, 2026, 5(2): 679-689. https://doi.org/10.12677/jcpm.2026.52171

参考文献

[1] 莫淼, 王泽洲, 郑莹, 等. 2022年全球及中国乳腺癌流行病学特征分析[J]. 海军军医大学学报, 2025, 46(4): 497-503.
[2] Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. [Google Scholar] [CrossRef] [PubMed]
[3] Sun, K., Zhang, B., Lei, S., Zheng, R., Liang, X., Li, L., et al. (2024) Incidence, Mortality, and Disability-Adjusted Life Years of Female Breast Cancer in China, 2022. Chinese Medical Journal, 137, 2429-2436. [Google Scholar] [CrossRef] [PubMed]
[4] Fisher, B., Anderson, S., Bryant, J., Margolese, R.G., Deutsch, M., Fisher, E.R., et al. (2002) Twenty-year Follow-Up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy Plus Irradiation for the Treatment of Invasive Breast Cancer. New England Journal of Medicine, 347, 1233-1241. [Google Scholar] [CrossRef] [PubMed]
[5] Gradishar, J.W., Moran, S.M., Abraham, J., et al. (2025) NCCN Guidelines® Insights: Breast Cancer, Version 5.2025. Journal of the National Comprehensive Cancer Network: JNCCN, 23, 426-436.
[6] Chachaj, A., Małyszczak, K., Pyszel, K., Lukas, J., Tarkowski, R., Pudełko, M., et al. (2010) Physical and Psychological Impairments of Women with Upper Limb Lymphedema Following Breast Cancer Treatment. Psycho-Oncology, 19, 299-305. [Google Scholar] [CrossRef] [PubMed]
[7] Wu, R., Huang, X., Dong, X., Zhang, H. and Zhuang, L. (2019) Obese Patients Have Higher Risk of Breast Cancer-Related Lymphedema than Overweight Patients after Breast Cancer: A Meta-analysis. Annals of Translational Medicine, 7, 172-172. [Google Scholar] [CrossRef] [PubMed]
[8] Zhang, W., Liu, Z., Li, J., Zhang, H., Wu, M., Yang, P., et al. (2025) Effect of Body Mass Index on Postoperative Lymphedema after Breast Cancer: A Systematic Review and Meta-Analysis. Discover Oncology, 16, Article No. 1758. [Google Scholar] [CrossRef
[9] Lin, C., Su, J., Wu, A.J., Lin, N., Hossack, M., Shi, W., et al. (2025) External Validation of a 5-Factor Risk Model for Breast Cancer-Related Lymphedema. JAMA Network Open, 8, e2455383. [Google Scholar] [CrossRef] [PubMed]
[10] Behroozian, T., Bonomo, P., Patel, P., Kanee, L., Finkelstein, S., van den Hurk, C., et al. (2023) Multinational Association of Supportive Care in Cancer (MASCC) Clinical Practice Guidelines for the Prevention and Management of Acute Radiation Dermatitis: International Delphi Consensus-Based Recommendations. The Lancet Oncology, 24, e172-e185. [Google Scholar] [CrossRef] [PubMed]
[11] Dayan, J.H., Ly, C.L., Kataru, R.P. and Mehrara, B.J. (2018) Lymphedema: Pathogenesis and Novel Therapies. Annual Review of Medicine, 69, 263-276. [Google Scholar] [CrossRef] [PubMed]
[12] Dylke, E.S., Benincasa Nakagawa, H., Lin, L., Clarke, J.L. and Kilbreath, S.L. (2018) Reliability and Diagnostic Thresholds for Ultrasound Measurements of Dermal Thickness in Breast Lymphedema. Lymphatic Research and Biology, 16, 258-262. [Google Scholar] [CrossRef] [PubMed]
[13] Balakin, E., Yurku, K., Ivanov, M., Izotov, A., Nakhod, V. and Pustovoyt, V. (2025) Regulation of Stress-Induced Immunosuppression in the Context of Neuroendocrine, Cytokine, and Cellular Processes. Biology, 14, Article 76. [Google Scholar] [CrossRef] [PubMed]
[14] Gursen, C., Meeus, M., Verbeelen, K., Vets, N., Spincemaille, L., Smeets, A., et al. (2025) Lymphsens Study: The Enigma of Subjective Lymphoedema—How Often and Why Do Patients Report Lymphoedema after Breast Cancer Treatment without an Objective Measurable Swelling? The Role of Lymphatic and Sensory Processing Problems: A Protocol for a Multicentre Prospective Longitudinal Study. BMJ Open, 15, e099990. [Google Scholar] [CrossRef] [PubMed]
[15] Gandhi, A., et al. (2023) Prospective, Early Longitudinal Assessment of Lymphedema-Related Quality of Life among Patients with Locally Advanced Breast Cancer: The Foundation for Building a Patient-Centered Screening Program. The Breast, 68, 205-215.
[16] Cano‐Lallave, E., Frutos‐Bernal, E., Anciones‐Polo, M., Serrano‐Sánchez, E., Rodríguez‐Guerrero, I., Cuenda‐Gamboa, P., et al. (2025) Optimizing Lymphedema Management after Breast Cancer: Predictive Risk Models in Clinical Practice. Journal of Surgical Oncology, 131, 1628-1636. [Google Scholar] [CrossRef] [PubMed]